<已截止> 2023/6/15 (Thur)【Drug Safety Series】Key PV inspection findings -The difference between US vs UK/EU

1. Real Example of an EU PV Inspection
a. Presenting a real EU PV inspection setting
b. Introducing a real standard question
c. Presenting a real critical PV finding
2. EU PV Inspection Procedure
a. Which EU authority will come to you?...

在〈<已截止> 2023/6/15 (Thur)【Drug Safety Series】Key PV inspection findings -The difference between US vs UK/EU〉中留言功能已關閉

【召集人專欄】<藥物安全系列二> Efficacy versus Safety, which comes first? (Liang-Ni Wu)

Further to my Introduction to Drug Safety Series posted in August 2016, I did not expect to a hot discussion over this not-so-popular topic. Indeed, there were only two comments posted - but I was surprised, and quite amazed to read these comments...

在〈【召集人專欄】<藥物安全系列二> Efficacy versus Safety, which comes first? (Liang-Ni Wu)〉中留言功能已關閉